These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25733260)

  • 61. Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria).
    Chlebeck PT; Milliner DS; Smith LH
    Am J Kidney Dis; 1994 Feb; 23(2):255-9. PubMed ID: 8311084
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitation of stone burden: imaging advances.
    Vrtiska TJ
    Urol Res; 2005 Nov; 33(5):398-402. PubMed ID: 16284880
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A young patient with end-stage renal disease, dyspnoea, weakness, peripheral neuropathy and an unsuspected underlying disease.
    Wichmann G; Passauer J; Fischer R; Weise M; Gross P
    Nephrol Dial Transplant; 2003 Aug; 18(8):1670-2. PubMed ID: 12897114
    [No Abstract]   [Full Text] [Related]  

  • 64. Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population.
    Jakobsen AK; Jacobsson LTH; Patschan O; Hopfgarten T; Askling J; Kristensen LE
    Scand J Urol; 2015 Dec; 49(6):486-491. PubMed ID: 26389795
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biochemical diagnosis in 3040 kidney stone formers in Argentina.
    Spivacow FR; del Valle EE; Negri AL; Fradinger E; Abib A; Rey P
    Urolithiasis; 2015 Aug; 43(4):323-30. PubMed ID: 25958053
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary and secondary hyperoxaluria: Understanding the enigma.
    Bhasin B; Ürekli HM; Atta MG
    World J Nephrol; 2015 May; 4(2):235-44. PubMed ID: 25949937
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Navigating the Evolving Landscape of Primary Hyperoxaluria: Traditional Management Defied by the Rise of Novel Molecular Drugs.
    Huang Y; Zhu W; Zhou J; Huang Q; Zeng G
    Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785918
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GC-MS based metabolite profiling, antioxidant and antiurolithiatic properties of apple cider vinegar.
    Singh AS; Singh A; Vellapandian C; Ramaswamy R; Thirumal M
    Future Sci OA; 2023 Apr; 9(4):FSO855. PubMed ID: 37090488
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.
    Groothoff JW; Metry E; Deesker L; Garrelfs S; Acquaviva C; Almardini R; Beck BB; Boyer O; Cerkauskiene R; Ferraro PM; Groen LA; Gupta A; Knebelmann B; Mandrile G; Moochhala SS; Prytula A; Putnik J; Rumsby G; Soliman NA; Somani B; Bacchetta J
    Nat Rev Nephrol; 2023 Mar; 19(3):194-211. PubMed ID: 36604599
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monogenic urinary lithiasis in Tunisian children: 25 years' experience of a referral center.
    Boussetta A; Karray A; Abida N; Jellouli M; Gargah T
    Tunis Med; 2022 mai; 100(5):410-415. PubMed ID: 36206091
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Primary hyperoxaluria type 1: urologic and therapeutic management.
    Kohli H; Kurtz MP
    Clin Kidney J; 2022 May; 15(Suppl 1):i14-i16. PubMed ID: 35592623
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structural and chemical heterogeneities of primary hyperoxaluria kidney stones from pediatric patients.
    Du Y; Roger VB; Mena J; Kang M; Stoller ML; Ho SP
    J Pediatr Urol; 2021 Apr; 17(2):214.e1-214.e11. PubMed ID: 33495102
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent advances in the identification and management of inherited hyperoxalurias.
    Sas DJ; Harris PC; Milliner DS
    Urolithiasis; 2019 Feb; 47(1):79-89. PubMed ID: 30535828
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular basis of primary hyperoxaluria: clues to innovative treatments.
    Dindo M; Conter C; Oppici E; Ceccarelli V; Marinucci L; Cellini B
    Urolithiasis; 2019 Feb; 47(1):67-78. PubMed ID: 30430197
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of renal stones in children: a comparison between percutaneous nephrolithotomy and shock wave lithotripsy.
    Shokeir AA; Sheir KZ; El-Nahas AR; El-Assmy AM; Eassa W; El-Kappany HA
    J Urol; 2006 Aug; 176(2):706-10. PubMed ID: 16813924
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi.
    Marguet CG; Springhart WP; Tan YH; Patel A; Undre S; Albala DM; Preminger GM
    BJU Int; 2005 Nov; 96(7):1097-100. PubMed ID: 16225535
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Percutaneous treatment of large upper tract stones after urinary diversion.
    el-Nahas AR; Eraky I; el-Assmy AM; Shoma AM; el-Kenawy MR; Abdel-Latif M; Mosbah A; Abol-Enein H; Shaaban AA; Mohsen T; el-Kappany HA
    Urology; 2006 Sep; 68(3):500-4. PubMed ID: 16979745
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ureteroscopic management of renal calculi in anomalous kidneys.
    Weizer AZ; Springhart WP; Ekeruo WO; Matlaga BR; Tan YH; Assimos DG; Preminger GM
    Urology; 2005 Feb; 65(2):265-9. PubMed ID: 15708035
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Surgical management of stone disease in patients with primary hyperoxaluria.
    Carrasco A; Granberg CF; Gettman MT; Milliner DS; Krambeck AE
    Urology; 2015 Mar; 85(3):522-6. PubMed ID: 25733260
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.